TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.000
+0.010 (0.50%)
At close: May 15, 2026, 4:00 PM EDT
1.992
-0.008 (-0.41%)
After-hours: May 15, 2026, 7:19 PM EDT
TherapeuticsMD Revenue
TherapeuticsMD had revenue of $724.00K in the quarter ending March 31, 2026, with 84.22% growth. This brings the company's revenue in the last twelve months to $3.35M, up 82.13% year-over-year. In the year 2025, TherapeuticsMD had annual revenue of $3.02M with 71.61% growth.
Revenue (ttm)
$3.35M
Revenue Growth
+82.13%
P/S Ratio
6.90
Revenue / Employee
$3,353,000
Employees
1
Market Cap
23.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.02M | 1.26M | 71.61% |
| Dec 31, 2024 | 1.76M | 459.00K | 35.25% |
| Dec 31, 2023 | 1.30M | -68.66M | -98.14% |
| Dec 31, 2022 | 69.96M | 67.39M | 2,619.12% |
| Dec 31, 2021 | 2.57M | -62.30M | -96.03% |
| Dec 31, 2020 | 64.87M | 15.23M | 30.67% |
| Dec 31, 2019 | 49.65M | 33.55M | 208.38% |
| Dec 31, 2018 | 16.10M | -678.20K | -4.04% |
| Dec 31, 2017 | 16.78M | -2.58M | -13.32% |
| Dec 31, 2016 | 19.36M | -786.40K | -3.90% |
| Dec 31, 2015 | 20.14M | 5.12M | 34.05% |
| Dec 31, 2014 | 15.03M | 6.25M | 71.23% |
| Dec 31, 2013 | 8.78M | 4.96M | 129.85% |
| Dec 31, 2012 | 3.82M | 1.73M | 82.84% |
| Dec 31, 2011 | 2.09M | 846.26K | 68.14% |
| Dec 31, 2010 | 1.24M | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | 941.86K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| InterCure | 84.76M |
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 62.64M |
| Zhengye Biotechnology Holding | 16.64M |
| China Pharma Holdings | 4.14M |
| Akanda | 836.66K |
| BioXcel Therapeutics | 642.00K |
| Incannex Healthcare | 12.00K |
TXMD News
- 4 days ago - TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year - TheFly
- 4 days ago - TherapeuticsMD Announces First Quarter 2026 Financial Results - Business Wire
- 6 weeks ago - TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year - TheFly
- 6 weeks ago - TherapeuticsMD Announces Full Year 2025 Financial Results - Business Wire
- 6 months ago - TherapeuticsMD reports Q3 EPS 0c vs. (5c) last year - TheFly
- 6 months ago - TherapeuticsMD Announces Third Quarter 2025 Financial Results - Business Wire
- 9 months ago - TherapeuticsMD reports Q2 EPS 5c vs. (9c) last year - TheFly
- 9 months ago - TherapeuticsMD Announces Second Quarter 2025 Financial Results - Business Wire